TRIM28 and prostate carcinoma: Since treatment of LNCaP prostate cancer cells with the antiandrogen enzalutamide promotes the expression of transposable elements [11], we hypothesized that combining Trim28 deletion with androgen deprivation (castration) would increase ERV expression.